Cargando…
2′-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model
A nanoparticle (NP) formulation with 2′-(2-bromohexadecanoyl)-paclitaxel (Br-16-PX) conjugate was developed in these studies for the treatment of non-small cell lung cancer (NSCLC). The lipophilic paclitaxel conjugate Br-C16-PX was synthesized and incorporated into lipid NPs where the 16-carbon chai...
Autores principales: | Peng, Lei, Schorzman, Allison N, Ma, Ping, Madden, Andrew J, Zamboni, William C, Benhabbour, Soumya Rahima, Mumper, Russell J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124067/ https://www.ncbi.nlm.nih.gov/pubmed/25114529 http://dx.doi.org/10.2147/IJN.S66040 |
Ejemplares similares
-
Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo
por: Feng, Lan, et al.
Publicado: (2011) -
Steroid Eluting Esophageal-Targeted Drug Delivery Devices for Treatment of Eosinophilic Esophagitis
por: Prasher, Alka, et al.
Publicado: (2021) -
Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective
por: Lucas, Andrew T., et al.
Publicado: (2021) -
Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy
por: Young, Isabella C., et al.
Publicado: (2021) -
Glioblastoma Multiforme—A Look at the Past and a Glance at the Future
por: King, Jasmine L., et al.
Publicado: (2021)